Browse grants
Federal opportunities with plain-English eligibility summaries. We aggregate public records — always verify the details on the funder’s site before applying.
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
Due Nov 2, 2028National Institutes of Health · Amount varies
This NIH/NHLBI UG3/UH3 cooperative agreement funds a Clinical Coordinating Center to lead and operate investigator-initiated multi-site clinical trials relevant to the NHLBI mission. A companion Data Coordinating Center application must be submitted on the same due date. Both U.S. and foreign organizations may apply, but applications with funded foreign subawards/subcontracts will be rejected.
ResearchersSchools & universitiesBroad eligibilityData Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
Due Nov 2, 2028National Institutes of Health · Amount varies
This NIH/NHLBI U24 cooperative agreement funds a Data Coordinating Center to provide data management, biostatistics, and project coordination for investigator-initiated multi-site clinical trials. A companion Clinical Coordinating Center application must be submitted on the same due date for consideration. Both U.S. and foreign organizations may apply, but applications with funded foreign subawards/subcontracts will be rejected.
ResearchersSchools & universitiesBroad eligibilitySingle-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Due Nov 2, 2028National Institutes of Health · Amount varies
This NIH/NHLBI R61/R33 cooperative agreement funds investigator-initiated single-site clinical trials relevant to the NHLBI mission, using a milestone-driven, two-phase structure. Both U.S. and foreign organizations may apply, but applications including funded foreign subawards/subcontracts will be deemed noncompliant. Applicants are encouraged to include expertise in biostatistics and clinical trial design.
ResearchersSchools & universitiesBroad eligibilityEarly Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Due Nov 5, 2028National Institutes of Health · Up to $400K
This NIH R01 grant funds research into early immune system development from the prenatal period through early childhood, including effects of in-utero HIV or antiretroviral exposure. A broad range of applicants is eligible, including colleges and universities, tribal governments, faith- and community-based organizations, minority-serving institutions, and foreign organizations. The award ceiling is up to about $400,000.
ResearchersSchools & universitiesNonprofitsGovernment / tribal+1 moreThe Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
Due Nov 22, 2028National Institutes of Health · Up to $500K
This NIH/NCI U01 cooperative agreement funds research projects within the Metastasis Research Network that use systems-level approaches to study cancer metastasis as a whole-body problem. Both U.S. and foreign organizations may apply, but applications including funded foreign subawards/subcontracts will be deemed noncompliant. The award ceiling is up to about $500,000.
ResearchersSchools & universitiesLarge awardBroad eligibilityResearch Grants in Clinical Informatics (R01 Clinical Trial Optional)
Due Mar 5, 2029National Institutes of Health · $0–$250K
This NIH/NLM R01 grant funds research teams developing and evaluating clinical informatics tools and methods that turn health data (such as electronic health records, clinical notes, and imaging) into actionable knowledge. Both U.S. and foreign organizations are eligible to apply, but applications involving funded foreign subawards/subcontracts will be rejected under NIH's post-May-2025 policy. The award ceiling is up to about $250,000.
ResearchersSchools & universitiesBroad eligibilityAdvancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
Due Mar 5, 2029National Institutes of Health · Up to $250K
This NIH/NLM R01 grant supports research advancing bioinformatics, translational bioinformatics, and computational biology, including AI and machine-learning methods for interpreting large biological datasets. Both U.S. and foreign organizations may apply, but applications that include funded foreign subawards/subcontracts will be deemed noncompliant and not considered. The award ceiling is up to about $250,000.
ResearchersSchools & universitiesBroad eligibilityARMY APPLICATIONS LAB BROAD AGENCY ANNOUNCEMENT FOR DISRUPTIVE APPLICATIONS
Due Apr 4, 2029Dept of the Army -- Materiel Command · Amount varies
The Army Applications Lab Broad Agency Announcement funds basic and applied scientific research in defense-relevant areas described in the BAA. Eligibility is unusually broad: institutions of higher education, nonprofits, state and local governments, foreign organizations and public entities, and for-profit businesses (large and small) may all apply. No specific award amount is listed, and projects are selected through full and open competition, so applicants should review the BAA's stated research areas of interest.
ResearchersSmall businessNonprofitsSchools & universities+2 moreCHIPS Research and Development Office (CRDO) Broad Agency Announcement (BAA)
Due Sep 30, 2029National Institute of Standards and Technology · From $10M
This NIST CHIPS R&D Office Broad Agency Announcement funds research, prototyping, and commercial solutions that advance U.S. microelectronics technology, with a stated floor of about $10 million per award. Eligible applicants include for-profit and non-profit organizations, accredited universities, FFRDCs, and federal entities, but they must be domestic; individuals and unincorporated sole proprietors are not eligible. Some foreign partners may participate as subawardees, subject to restrictions (foreign adversaries excluded). Given the large award size, applicants should review the full BAA for compliance requirements.
Small businessNonprofitsSchools & universitiesResearchers+3 moreAir Dominance Broad Agency Announcement (BAA)
Due Oct 31, 2029Munitions Directorate · Up to $750M
This Air Force (Munitions Directorate) Broad Agency Announcement funds research and development supporting air dominance, with a program ceiling reported up to roughly $750 million. Eligibility is described as unrestricted and open to any type of entity, subject to any clarifications in the full announcement, making it broadly accessible to businesses, universities, and nonprofits. Because it is defense-focused R&D, applicants should expect security and compliance requirements and should review the full BAA for specifics.
ResearchersSmall businessNonprofitsSchools & universities+3 moreRFA-CC-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-CC-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The listing is a placeholder for Type 6 (continuation/competing renewal) applications and gives no award amounts or program details. As it appears geared toward existing grantees, verify with CDC whether new organizations can apply.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-DP-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-DP-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The entry is a placeholder for Type 6 (continuation/competing renewal) applications and does not list award amounts or program details. As it appears geared toward existing grantees, check with CDC about eligibility before applying as a new organization.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-CK-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-CK-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is listed only as a placeholder for Type 6 (continuation/competing renewal) applications, with no award amounts or specific requirements provided. Because it appears intended for existing grantees, confirm with CDC whether new applicants can apply.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-IP-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-IP-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The entry is a placeholder for Type 6 (continuation/competing renewal) applications and does not state award amounts or program specifics. Because it appears aimed at existing grantees, check with CDC about eligibility if you have not held a prior award.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-EH-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-EH-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is a placeholder for Type 6 (continuation/competing renewal) applications, with no stated award amounts or detailed requirements. Because it appears aimed at existing grantees, confirm eligibility with CDC if you are a first-time applicant.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-TS-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-TS-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The listing is a placeholder for Type 6 (continuation/competing renewal) applications and does not state award amounts or detailed program requirements. Since it appears aimed at existing grantees filing renewal-type applications, verify eligibility with CDC if you are a first-time applicant.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-CD-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-CD-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is a placeholder for Type 6 (continuation/competing renewal) applications, with no stated award amounts or specific requirements. Because it appears aimed at existing grantees, confirm eligibility with CDC if you are a first-time applicant.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-OE-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-OE-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is listed only as a placeholder for Type 6 (continuation/competing renewal) applications, with no award amounts or detailed requirements. Since it appears intended for existing grantees, confirm eligibility with CDC before applying as a new applicant.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-TP-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-TP-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The entry is a placeholder for Type 6 (continuation/competing renewal) applications and does not list award amounts or program details. Since it appears intended for existing grantees, check with CDC about eligibility before applying as a new organization.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-PS-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-PS-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The listing is a placeholder for Type 6 (continuation/competing renewal) applications and provides no award amounts or specific program details. Since it appears intended for existing grantees, verify with CDC whether new applicants are eligible.
NonprofitsSmall businessResearchersGovernment / tribal+2 more